EPO Patents = 1

Forward Citations = 23

Loading Chart...

8 inventors (with patents filed for the assignee):

John Ford (4 out of 6 patents)

Patrick Round (3 out of 5 patents)

John Kastelein (3 out of 5 patents)

4. Atsuhiro Kawaguchi (2 out of 4 patents)

5. Koichi Tomiyasu (2 out of 4 patents)

6. Kozo Oka (2 out of 7 patents)

7. Johannes Paulus Gerardus Seerden (1 out of 1 patent)

8. Amandine Ledru (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11013742 - Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases (2021-05-25),

2. 10653692 - Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases (2020-05-19),

3. 10300059 - Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors (2019-05-28),

4. 10112904 - Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives (2018-10-30),

Dezima Pharma B.V. is a biotechnology company focused on developing innovative therapies for the treatment of cardiovascular diseases. Founded in 2012, the company is headquartered in Naarden, Netherlands. Dezima Pharma is committed to advancing drug discovery and development to address the global burden of cardiovascular disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#1 in DC Narden

#1,305 in Netherlands

DC Narden, Netherlands

Dezima Pharma B.v.